Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Physical activity in older adults linked to brain white-matter integrity

  • Researchers discover how circular RNA is created, find link to degenerative disease

  • Providing private mental health service to veterans: Hurdles, challenges, advice

  • Cooling of dialysis fluids protects against brain damage

  • Mycotoxin present in many types of food deteriorates neuroregeneration

  • Mitochondria's role in neurodegenerative diseases clearer thanks to mouse study

  • Sibling bullying linked to later depression, self-harm

  • Simple test can help detect Alzheimer's before dementia signs show, study shows

  • Single dose of antidepressant changes the brain

  • Novel mechanism involved in memory discovered

  •